Catherine M. Burzik - Jan 5, 2023 Form 4/A - Amendment Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Patrick Keran, attorney-in-fact
Stock symbol
OFIX
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/9/2023, 05:07 PM
Date Of Original Report
Jan 9, 2023
Previous filing
Aug 8, 2022
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +14.4K +76.75% $0.00 33.1K Jan 5, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.
F2 This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.
F3 Includes 29,174 deferred stock units.